Changeflow GovPing Healthcare & Life Sciences HSA Singapore: Adverse Effects from Banned Medi...
Priority review Notice Added Final

HSA Singapore: Adverse Effects from Banned Medicinal Products

Favicon for www.hsa.gov.sg HSA Singapore Announcements
Detected
Email

Summary

HSA Singapore has issued a notice regarding adverse effects reported after consumers took banned medicinal products. The agency is highlighting the risks associated with using unapproved health products and urges consumers to exercise caution.

Published by HSA on hsa.gov.sg . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Health Sciences Authority (HSA) of Singapore has released a notice detailing adverse effects experienced by consumers who ingested banned medicinal products. This announcement serves to alert the public and healthcare professionals about the potential dangers of unapproved health products, emphasizing that these products have not undergone safety and quality evaluations by HSA and may contain potent ingredients or undeclared Western medicines.

Consumers are strongly advised to cease using any banned medicinal products and to consult a doctor if they experience adverse effects. Healthcare providers are encouraged to be vigilant and report any suspected adverse reactions linked to such products. The notice underscores the importance of relying on legitimate and approved health products to ensure personal safety and well-being.

What to do next

  1. Consumers should cease use of banned medicinal products and consult a doctor if experiencing adverse effects.
  2. Healthcare providers should remain vigilant for adverse effects potentially linked to banned products and report them to HSA.

Archived snapshot

Mar 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Press Releases

Get daily alerts for HSA Singapore Announcements

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from HSA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
HSA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Consumers Healthcare providers
Activity scope
Product Safety
Geographic scope
Singapore SG

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Product Safety Consumer Protection

Get alerts for this source

We'll email you when HSA Singapore Announcements publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!